Check this page for latest news updates and breaking headlines on the coronavirus 'COVID-19' pandemic and its impact in Australia and around the world.
GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older: London, UK Wednesday, February 11, 2026, 09:00 Hrs [IST] GSK plc announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results